Metacrine-Logo-R.jpg
Metacrine to Present at Jefferies 2019 London Healthcare Conference
November 18, 2019 07:30 ET | Metacrine, Inc.
SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine-Logo-R.jpg
Metacrine Secures $50 Million Growth Capital Facility from K2 HealthVentures
September 18, 2019 07:30 ET | Metacrine, Inc.
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine-Logo-R
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
May 21, 2019 07:30 ET | Metacrine, Inc.
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine logo.jpg
Metacrine Appoints Hubert Chen, M.D. as Chief Medical Officer and Andrew Guggenhime to the Board of Directors
September 06, 2018 07:30 ET | Metacrine, Inc.
SAN DIEGO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., a biotechnology company developing therapies to benefit patients with liver and gastrointestinal diseases (GI), today announced the...
Atlantic Healthcare
Atlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indication
May 22, 2017 08:00 ET | Atlantic Healthcare plc
CAMBRIDGE, U.K., May 22, 2017 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)...